Biobest is highlighting the benefits of using its canine prostate specific arginine esterase (CPSE) test to differentiate between those dogs which have benign prostatic hyperplasia and those suffering more serious conditions, such as neoplasia.
Benign prostatic hyperplasia is a common condition of entire dogs with over 50% of dogs over 5 years of showing histological evidence of BPH.
Paul Burr MRCVS from Biobest said: "While the clinical stages of prostatic disease are not difficult to diagnose, differentiating BPH from other causes of prostatic disease such as prostatic cysts, prostatitis, prostatic abscesses or neoplasia is less simple. Traditionally further investigation would include bacteriology and cytology on a prostatic wash or final needle aspirate, and prostatic ultrasonography."
Although the CPSE test has been available for a couple of years now, Paul says the benefits of the test have not thus far been well-explained: "I think most vets probably think it's just a test for Prostatic Disease, something which is easy enough to diagnose without testing.
"While the test can be used as part of an annual check up to look for pre-clinical BPH in entire male dogs, it's real value is that it is a simple, convenient non-invasive blood test that helps determine whether a dog presenting with signs of prostatic disease is most likely to be suffering from BPH or a more serious condition that requires further investigation."
For more information about the CPSE test, contact Biobest on 0131 440 2628 or email enquiry@biobest.co.uk.